1,125 Results
SpyGlass Pharma names Shannon Treviño as General Counsel as BIM-IOL Phase 3 trials enroll and an NDA submission moves closer.
Vaibhavi M. | Jun 15, 2026
Betterbrand markets BetterLungs for wildfire smoke exposure as 2026 AQI levels exceed safe thresholds across multiple U.S. regions.
Vaibhavi M. | Jun 15, 2026
FDA consolidates human drug import requirements under FD&C Act and 21 CFR, covering CGMP, establishment registration, labeling, and API compliance.
Vaibhavi M. | Jun 15, 2026
FDA's final PLAIR guidance sets 60- and 120-day import windows for pre-approval finished drugs, with submission routed through the CDER NexGen Portal.
Vaibhavi M. | Jun 15, 2026
FDA's risk-based import admissibility framework ties GMP compliance under 21 CFR Parts 210 and 211 directly to shipment entry decisions.
Vaibhavi M. | Jun 15, 2026
ACG's Golden Batch and Chanakya systems close the loop from AI insight to machine execution, lifting first-pass yield and cutting defect PPM.
Vaibhavi M. | Jun 15, 2026
Medtronic brings its PulseSelect PFA system to India, expanding access to cardiac ablation in a key emerging market.
Vaibhavi M. | Jun 15, 2026